Top compounds associated with response to MYO3B


Feature Type Standardized
Nominal ANOVA
mRNA BX-795 GDSC1000 pan-cancer AAC -0.098 0.005
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.087 0.005
mRNA QS11 GDSC1000 pan-cancer AAC -0.1 0.005
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.091 0.005
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.005
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.093 0.006
mRNA XL-184 GDSC1000 pan-cancer AAC -0.094 0.006
mRNA embelin GDSC1000 pan-cancer AAC -0.097 0.006
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.007
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.085 0.007
Download CSV